Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Metabolic pathways associated with right ventricular adaptation to pulmonary hypertension: 3D analysis of cardiac magnetic resonance imaging.

Attard MI, Dawes TJW, de Marvao A, Biffi C, Shi W, Wharton J, Rhodes CJ, Ghataorhe P, Gibbs JSR, Howard LSGE, Rueckert D, Wilkins MR, O'Regan DP.

Eur Heart J Cardiovasc Imaging. 2019 Jun 1;20(6):668-676. doi: 10.1093/ehjci/jey175.

2.

Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension.

Harbaum L, Ghataorhe P, Wharton J, Jiménez B, Howard LSG, Gibbs JSR, Nicholson JK, Rhodes CJ, Wilkins MR.

Thorax. 2019 Apr;74(4):380-389. doi: 10.1136/thoraxjnl-2018-212144. Epub 2018 Nov 26.

3.

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.

Rhodes CJ, Wharton J, Ghataorhe P, Watson G, Girerd B, Howard LS, Gibbs JSR, Condliffe R, Elliot CA, Kiely DG, Simonneau G, Montani D, Sitbon O, Gall H, Schermuly RT, Ghofrani HA, Lawrie A, Humbert M, Wilkins MR.

Lancet Respir Med. 2017 Sep;5(9):717-726. doi: 10.1016/S2213-2600(17)30161-3. Epub 2017 Jun 15.

4.

Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.

Ghataorhe P, Rhodes CJ, Harbaum L, Attard M, Wharton J, Wilkins MR.

J Intern Med. 2017 Aug;282(2):129-141. doi: 10.1111/joim.12623. Epub 2017 May 19. Review.

5.

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.

Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, Bleda M, Haimel M, Coghlan G, Corris PA, Howard LS, Kiely DG, Peacock AJ, Pepke-Zaba J, Toshner MR, Wort SJ, Gibbs JS, Lawrie A, Gräf S, Morrell NW, Wilkins MR.

Circulation. 2017 Jan 31;135(5):460-475. doi: 10.1161/CIRCULATIONAHA.116.024602. Epub 2016 Nov 21.

6.

Corrigendum to "Abnormal frontostriatal connectivity in adolescent-onset schizophrenia and its relationship to cognitive functioning" [Eur. Psychiatry 35C (2016) 32-38].

James A, Joyce E, Lunn D, Hough M, Kenny L, Ghataorhe P, Fernandes HM, Matthews PM, Zarei M.

Eur Psychiatry. 2016 Oct;38:22. doi: 10.1016/j.eurpsy.2016.07.001. Epub 2016 Sep 8. No abstract available.

PMID:
27614143
7.

Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future.

Lythgoe MP, Rhodes CJ, Ghataorhe P, Attard M, Wharton J, Wilkins MR.

Pharmacol Ther. 2016 Aug;164:195-203. doi: 10.1016/j.pharmthera.2016.04.012. Epub 2016 Apr 29. Review.

8.

Abnormal frontostriatal connectivity in adolescent-onset schizophrenia and its relationship to cognitive functioning.

James A, Joyce E, Lunn D, Hough M, Kenny L, Ghataorhe P, Fernandes HM, Matthews PM, Zarei M.

Eur Psychiatry. 2016 May;35:32-8. doi: 10.1016/j.eurpsy.2016.01.2426. Epub 2016 Apr 7. Erratum in: Eur Psychiatry. 2016 Oct;38:22.

PMID:
27061375
9.

A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.

Ghataorhe P, Kurian AW, Pickart A, Trapane P, Norton JA, Kingham K, Ford JM.

Cancer Genet Cytogenet. 2007 Dec;179(2):89-92. Review.

PMID:
18036394

Supplemental Content

Loading ...
Support Center